Financial News Discussion of BMY - Bristol-Myers Squibb Company on Squawk On The Street

Financial News for Bristol-Myers Squibb Company (BMY)

BMY 3/19/2010 4:00PM 52 Week Price Range Market Capitalization Dividend Yield Recent Dividend
$26.01 $18.83 — $26.62 $44.7 Billion 4.90% $1.25

Want to Sharpen Your Investing?

Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.

Sign Up Now for Ockham's Stock Analysis and News Services

Explore Why Ockham?

Quality Analysis
Ockham has fundamental valuations on over 5000 companies which we distribute, to our clients via highly-focused equity reports, weekly newsletters, and analysts' daily market commentary blogs. (Learn More)
Crowd Sentiment
Through our partnership with The Motley Fool, Ockham provides the most robust data on investors' sentiment of individual stocks. This indicator, along with our valuations and our news tracking, helps our clients make informed investment decisions. (Learn More)
Financial News Slicing
With the influx of noise in our lives, it can be exceedingly difficult to separate the essential news from everything else. Ockham's RazorWire tool "slices" through business television and impactful blogs to provide you with the clearest information possible. (Learn More)
Bristol-Myers Squibb Company was discussed on Squawk On The Street which was originally produced by CNBC on 11/12/2009
Squawk On The Street discussed Bristol-Myers Squibb Company on 11/12/09. Mark Haines, who highlights news and stocks each day at 9:00 AM, mentioned Bristol-Myers Squibb Company on the program. The mention with surrounding context is displayed below.

The latest news from business television and influential blogs is always available through Ockham's RazorWire, and this news is in relation to Bristol-Myers Squibb Company.

Sent tweets. Is messages are often about drug study results, links to press releases or frivolous like pictures from a charity event. Others like BRISTOL-MYERS SQUIBB has created a twitter account but have yet to say anything. No company that i'm aware of is directly promoting a product on to figure out if or how that might eventually happen, today they start a two-day public hearing on pharma and social once a marketing director for

“ is directly promoting a product on to figure out if or how that might eventually happen, today they start a two-day public hearing on pharma and social once a marketing director for ” Squawk On The Street Nov 12, 2009 10:11 AM
A couple other items to be aware of: